PRWeb The Leader Press Release Distribution
See How PRWeb Works

We're here to help 1-866-640-6397

Login Create Free Account


All Press Releases for September 4, 2003 Subscribe to this News Feed    
 

Celer Pawlowsky (CPSL) meets 2003 sales target and grows by 25% YTD

During these highly successful eight months, the company extended its range of localization services, added major new clients from the USA and EU markets to its existing portfolio, became an official Trados Reseller and, in August, signed long-term contracts to act as a single multilingual vendor to two world-leaders of the pharmaceutical industry.

September, 2003 -- CPSL, one of the main European language-providers, announced at the end of August that the company has met its annual sales target for 2003. As a result, the company has achieved a 25% increase in revenue year-to-date. With one quarter remaining the company is anticipating a further increase on revenue for the year.

During these highly successful eight months, the company extended its range of localization services, added major new clients from the USA and EU markets to its existing portfolio, became an official Trados Reseller and, in August, signed long-term contracts to act as a single multilingual vendor to two world-leaders of the pharmaceutical industry.

In addition to providing translation and consultancy services to international IT and telecom companies, CPSL is rapidly becoming the recognized reference within the healthcare industry both in Europe and in the States.

OPTIONS
Printer Friendly Version
Email this story to a colleague
CONTACT INFORMATION
Nuria Alvarez
Cpsl
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your PRWeb News Management Console.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appears here.